Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17001292rdf:typepubmed:Citationlld:pubmed
pubmed-article:17001292lifeskim:mentionsumls-concept:C0010346lld:lifeskim
pubmed-article:17001292lifeskim:mentionsumls-concept:C0812246lld:lifeskim
pubmed-article:17001292lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:17001292lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:17001292lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:17001292lifeskim:mentionsumls-concept:C0666743lld:lifeskim
pubmed-article:17001292lifeskim:mentionsumls-concept:C1706640lld:lifeskim
pubmed-article:17001292lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:17001292lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:17001292lifeskim:mentionsumls-concept:C0018591lld:lifeskim
pubmed-article:17001292lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:17001292pubmed:issue10lld:pubmed
pubmed-article:17001292pubmed:dateCreated2006-9-26lld:pubmed
pubmed-article:17001292pubmed:abstractTextInfliximab, a chimeric anti-tumour necrosis factor (TNF)-alpha antibody induces a clinical response in 70% of Crohn's disease patients and the response to infliximab therapy could be partially determined by genetic factors. The implication of both transmembrane and soluble forms of the TNF-alpha in the mechanism of action of infliximab has been demonstrated. The aim of our work was first to perform a complete study of TNF variants role in the response to infliximab in Crohn's disease. Secondly, considering the role of ADAM 17 in TNF-alpha shedding, the ADAM 17 locus was also studied. The response to infliximab was evaluated in 222 Caucasian Crohn's disease patients with a luminal (n=160) or fistulizing (n=62) form of the disease. Clinical and biological response evaluation was based on the Crohn's Disease Activity Index score and C-reactive protein level evolutions, respectively. The entire TNF gene was sequenced on the complete cohort. Twelve single nucleotide polymorphisms spanning the ADAM 17 locus were studied and haplotypes rebuilt. A clinical response was observed in 64% of the patients and biological response in 77.1% of patients. No association was found between the TNF gene and the response to infliximab. One haplotype in the ADAM 17 region was associated with a clinical response to infliximab in CD patients (adjusted P=0.045). In conclusion, our results exclude, with a reasonable power, an implication of the TNF gene in the response to infliximab in Crohn's disease, but reveal a potential role of the ADAM 17 gene in this response.lld:pubmed
pubmed-article:17001292pubmed:languageenglld:pubmed
pubmed-article:17001292pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17001292pubmed:citationSubsetIMlld:pubmed
pubmed-article:17001292pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17001292pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17001292pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17001292pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17001292pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17001292pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17001292pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17001292pubmed:statusMEDLINElld:pubmed
pubmed-article:17001292pubmed:monthOctlld:pubmed
pubmed-article:17001292pubmed:issn1744-6880lld:pubmed
pubmed-article:17001292pubmed:authorpubmed-author:FranchimontDe...lld:pubmed
pubmed-article:17001292pubmed:authorpubmed-author:RutgeertsPaul...lld:pubmed
pubmed-article:17001292pubmed:authorpubmed-author:LouisEdouardElld:pubmed
pubmed-article:17001292pubmed:authorpubmed-author:De...lld:pubmed
pubmed-article:17001292pubmed:authorpubmed-author:FarnirFrédéri...lld:pubmed
pubmed-article:17001292pubmed:authorpubmed-author:BelaicheJacqu...lld:pubmed
pubmed-article:17001292pubmed:authorpubmed-author:BoursVincentVlld:pubmed
pubmed-article:17001292pubmed:authorpubmed-author:VermeireSéver...lld:pubmed
pubmed-article:17001292pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:17001292pubmed:authorpubmed-author:DidebergVinci...lld:pubmed
pubmed-article:17001292pubmed:authorpubmed-author:ThéâtreEmilie...lld:pubmed
pubmed-article:17001292pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17001292pubmed:volume16lld:pubmed
pubmed-article:17001292pubmed:ownerNLMlld:pubmed
pubmed-article:17001292pubmed:authorsCompleteYlld:pubmed
pubmed-article:17001292pubmed:pagination727-34lld:pubmed
pubmed-article:17001292pubmed:meshHeadingpubmed-meshheading:17001292...lld:pubmed
pubmed-article:17001292pubmed:meshHeadingpubmed-meshheading:17001292...lld:pubmed
pubmed-article:17001292pubmed:meshHeadingpubmed-meshheading:17001292...lld:pubmed
pubmed-article:17001292pubmed:meshHeadingpubmed-meshheading:17001292...lld:pubmed
pubmed-article:17001292pubmed:meshHeadingpubmed-meshheading:17001292...lld:pubmed
pubmed-article:17001292pubmed:meshHeadingpubmed-meshheading:17001292...lld:pubmed
pubmed-article:17001292pubmed:meshHeadingpubmed-meshheading:17001292...lld:pubmed
pubmed-article:17001292pubmed:meshHeadingpubmed-meshheading:17001292...lld:pubmed
pubmed-article:17001292pubmed:meshHeadingpubmed-meshheading:17001292...lld:pubmed
pubmed-article:17001292pubmed:meshHeadingpubmed-meshheading:17001292...lld:pubmed
pubmed-article:17001292pubmed:meshHeadingpubmed-meshheading:17001292...lld:pubmed
pubmed-article:17001292pubmed:year2006lld:pubmed
pubmed-article:17001292pubmed:articleTitleThe TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease.lld:pubmed
pubmed-article:17001292pubmed:affiliationDepartment of Human Genetics, Centre for Biomedical Integrated Genoproteomics, University of Liège, Liège, Belgium. vinciane.dideberg@chu.ulg.ac.belld:pubmed
pubmed-article:17001292pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17001292pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17001292lld:pubmed